Performance analysis of Acasti Pharma (ACST)
Annual Return
Over the past 3 years, ACST has had an average annual return of +18.62%, underperforming the benchmark SPY, which returned +22% annual.
Over the past 5 years, ACST has had an average annual return of -47.00%, underperforming the benchmark SPY, which returned +9.88% annual.
Over the past 10 years, ACST has had an average annual return of -31.76%, underperforming the benchmark SPY, which returned +14.40% annual.
Since May 6, 2011, ACST has had an average annual return of -31.76%, underperforming the benchmark SPY, which returned +13.42% annual.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +7.27% | -3.51% | -60.42% | -51.35% | -86.74% | +194.59% | -11.55% | -24.76% | -50.99% | -48.99% | -60.00% | -41.86% |
| 2012 | 2011 | ||||||||||
| +62.15% | +20.83% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -14.55% | +34.04% | +3.17% | -18.46% | -1.89% | +5.77% | -7.27% | -1.96% | +14% | +3.51% | +7.27% | ||
| 2023 | +42.11% | -28.40% | -10.34% | +0% | +19.23% | -3.23% | -18.33% | -20.41% | +35.90% | -15.09% | -8.89% | +34.15% | -3.51% |
| 2022 | -9.03% | -2.29% | +8.59% | -13.67% | -6.67% | -12.50% | -4.08% | -1.06% | -29.03% | -3.03% | -25.00% | +18.75% | -60.42% |
| 2021 | +101.01% | +10.25% | -16.62% | -17.92% | +1.34% | +12.53% | -18.75% | -26.92% | -25.00% | -16.67% | -18.95% | -6.49% | -51.35% |
| 2020 | -70.22% | -41.05% | -11.73% | +60.69% | +3.24% | -25.44% | +61.92% | -67.82% | -18.39% | -7.14% | +56.21% | +12.12% | -86.74% |
| 2019 | +28.63% | +0.92% | -5.59% | -14.64% | +3.40% | +26.71% | +111.36% | -22.40% | +1.06% | -2.61% | +8.11% | +23.17% | +194.59% |
| 2018 | +20.19% | -11.55% | +1.98% | -24.43% | -10.40% | -17.49% | +3.66% | -5.20% | +130.59% | -22.53% | -27.00% | +13.98% | -11.55% |
| 2017 | +1.58% | -1.56% | +8.78% | -5.89% | +0.60% | +2.56% | +0% | -2.83% | +10.69% | -9.81% | +30.42% | -43.69% | -24.76% |
Drawdown analysis of Acasti Pharma (ACST)
The maximum drawdown for the ACST was -99.91%, occurring on Sep 22, 2023. This drawdown has not yet recovered.
The current ACST drawdown is -99.84%.
Since May 6, 2011 ACST has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 3 times
- 10% or more: 4 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.91% | Aug 5, 2013 | 2551 | Sep 22, 2023 | Ongoing | Ongoing | Ongoing |
| -26.08% | Jun 7, 2011 | 159 | Jan 24, 2012 | 15 | Feb 14, 2012 | 174 |
| -22.89% | Dec 6, 2012 | 71 | Mar 21, 2013 | 56 | Jun 11, 2013 | 127 |
| -18.34% | May 2, 2012 | 132 | Nov 9, 2012 | 14 | Nov 30, 2012 | 146 |
| -4.47% | Jul 30, 2013 | 2 | Aug 1, 2013 | 2 | Aug 5, 2013 | 4 |
| -3.67% | Mar 19, 2012 | 4 | Mar 23, 2012 | 23 | Apr 26, 2012 | 27 |
| -3.64% | Jun 11, 2013 | 3 | Jun 14, 2013 | 4 | Jun 20, 2013 | 7 |
| -3.34% | Jul 1, 2013 | 2 | Jul 3, 2013 | 2 | Jul 8, 2013 | 4 |
| -2.68% | May 17, 2011 | 2 | May 19, 2011 | 4 | May 25, 2011 | 6 |
| -1.92% | Jul 11, 2013 | 1 | Jul 12, 2013 | 1 | Jul 15, 2013 | 2 |
| -1.45% | Jun 20, 2013 | 2 | Jun 24, 2013 | 4 | Jun 28, 2013 | 6 |
| -1.30% | May 26, 2011 | 1 | May 27, 2011 | 4 | Jun 3, 2011 | 5 |
| -0.31% | Jul 24, 2013 | 2 | Jul 26, 2013 | 1 | Jul 29, 2013 | 3 |
| -0.15% | Nov 30, 2012 | 1 | Dec 3, 2012 | 1 | Dec 4, 2012 | 2 |
| -0.13% | Apr 27, 2012 | 1 | Apr 30, 2012 | 2 | May 2, 2012 | 3 |